| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1From the Wound Healing Research Unit, Department of Pathology and Glaucoma, Institute of Ophthalmology, London, United Kingdom; the 2Institute for Wound Research, University of Florida, Gainesville, Florida; and the 3Glaucoma Unit, Moorfields Eye Hospital, London, United Kingdom.
PURPOSE. To investigate the effect of matrix metalloproteinase (MMP) inhibition on fibroblast-mediated matrix contraction and production.
METHODS. Free-floating fibroblast–populated type I collagen lattices were prepared with human Tenon’s capsule fibroblasts. Lattice areas were photographed and digitally analyzed to indicate the degree of lattice contraction. Quantitative competitive reverse transcription–polymerase chain reaction (QCRT-PCR) and enzyme-linked immunosorbent assay (ELISA) were used to quantify mRNA and protein respectively for MMP-1, -2, and -3 by fibroblasts during lattice contraction. Gelatin zymography demonstrated activity of MMPs released into the conditioned medium of contracting lattices. Concentrations of the broad-spectrum MMP inhibitors ilomastat, CellTech (Slough, UK), and BB-94 were added to the contracting fibroblast-populated collagen lattices. Secreted C-terminal propeptide of type I collagen was measured in conditioned medium of contracting lattices by ELISA. Fibroblast proliferation in the presence of concentrations of ilomastat was measured by using the reagent water-soluble tetrazolium-1 (WST-1).
RESULTS. During contraction of type I collagen lattices, Tenon’s capsule fibroblasts expressed MMP-1, -2, and -3 mRNA and protein. Zymography demonstrated the release of four gelatinolytic species into the conditioned medium of contracting lattices (57, 72, 91, and 100 kDa). Inclusion of MMP inhibitors in the zymogram-developing buffer reduced the proteolytic activity of the detected bands. MMP inhibition (1–100 µM) significantly reduced fibroblast-mediated collagen lattice contraction (P < 0.05), and this effect was found to be reversible. Ilomastat also significantly inhibited production of collagen in a dose-dependent manner (P < 0.05). No effect on fibroblast proliferation was found in the presence of ilomastat.
CONCLUSIONS. MMPs are produced during Tenon’s capsule fibroblast-mediated collagen lattice contraction. Broad-spectrum MMP inhibition significantly reduced matrix contraction and production without cell toxicity. Future clinical use of MMP inhibitors may be possible, because MMP inhibition significantly reduces fibroblast functions associated with contractile scarring.
This article has been cited by other articles:
|
|
 |
|
  W.-C. Wu, C.-C. Lai, H. S.-L. Chen, M.-H. Sun, L.-M. Lee, C.-P. Shih, H. W.-H. Lee, and W.-C. Hsu Efficacy and Safety of Biodegradable Collagen-Glycosaminoglycan Polymer as a Material for Scleral Buckling Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2673 - 2678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Awasthi, S. T. Wang-Su, and B. J. Wagner Downregulation of MMP-2 and -9 by Proteasome Inhibition: A Possible Mechanism to Decrease LEC Migration and Prevent Posterior Capsular Opacification Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1998 - 2003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.T.W. McKeown, J.J. Barnes, P.L. Hyland, F.T. Lundy, M.J. Fray, and C.R. Irwin Matrix Metalloproteinase-3 Differences in Oral and Skin Fibroblasts J. Dent. Res., May 1, 2007; 86(5): 457 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Arnoczky, M. Lavagnino, M. Egerbacher, O. Caballero, and K. Gardner Matrix Metalloproteinase Inhibitors Prevent a Decrease in the Mechanical Properties of Stress-Deprived Tendons: An In Vitro Experimental Study Am. J. Sports Med., May 1, 2007; 35(5): 763 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Priglinger, C. S. Alge, D. Kook, M. Thiel, R. Schumann, K. Eibl, A. Yu, A. S. Neubauer, A. Kampik, and U. Welge-Lussen Potential role of tissue transglutaminase in glaucoma filtering surgery. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3835 - 3845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T. L. Wong, A. L. Mead, and P. T. Khaw Prolonged Antiscarring Effects of Ilomastat and MMC after Experimental Glaucoma Filtration Surgery Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2018 - 2022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Limb, K. Matter, G. Murphy, A. D. Cambrey, P. N. Bishop, G. E. Morris, and P. T. Khaw Matrix Metalloproteinase-1 Associates with Intracellular Organelles and Confers Resistance to Lamin A/C Degradation during Apoptosis Am. J. Pathol., May 1, 2005; 166(5): 1555 - 1563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Esson, M. P. Popp, L. Liu, G. S. Schultz, and M. B. Sherwood Microarray Analysis of the Failure of Filtering Blebs in a Rat Model of Glaucoma Filtering Surgery Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4450 - 4462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T T L Wong, J T Daniels, J G Crowston, and P T Khaw MMP inhibition prevents human lens epithelial cell migration and contraction of the lens capsule Br. J. Ophthalmol., July 1, 2004; 88(7): 868 - 872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Daniels, G. S. Schultz, T. D. Blalock, Q. Garrett, G. R. Grotendorst, N. M. Dean, and P. T. Khaw Mediation of Transforming Growth Factor-{beta}1-Stimulated Matrix Contraction by Fibroblasts: A Role for Connective Tissue Growth Factor in Contractile Scarring Am. J. Pathol., November 1, 2003; 163(5): 2043 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T. L. Wong, A. L. Mead, and P. T. Khaw Matrix Metalloproteinase Inhibition Modulates Postoperative Scarring after Experimental Glaucoma Filtration Surgery Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1097 - 1103. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
